Connecticut Laws

Connecticut Laws & Regulations

The information contained on this website is provided for informational purposes only and should not be construed as legal advice on any matter. The Information constitutes general information of applicable administrative regulation and/or laws related to general topics in the arena of controlled substance misuse and abuse and may not reflect current legal developments and updates. Please refer to your state legislature for any potential changes. 

CT Administrative Code (CAC)

CT Comprehensive Drug Laws – Commission of Pharmacy (2022)

General Statutes of Connecticut – Revised to January 1, 2023 (GSC)

2024 Supplement to the General Statutes of Connecticut – Revised to January 1, 2024 (GSC24)

Connecticut Advertising/Marketing Information

• GSC24 Sec. 21a-93 – (Formerly Sec. 19-213). Prohibited acts.
• GSC Sec. 21a-113 – (Formerly Sec. 19-232). False advertisement of food, drugs, devices and cosmetics.
• GSC Sec. 21a-126 – (Formerly Sec. 19-240). Definitions.
• GSC Sec. 21a-127 – (Formerly Sec. 19-241). Illegal advertising.
• GSC24 – Sec. 21a-409 – Manufacture, marketing, cultivation and storage of hemp and hemp products.
• GSC24 – Sec. 21a-70j – Disclosure by pharmaceutical sales representative engaged in legend drug marketing to prescribing practitioner or pharmacist.
• CT OLR – CT Drug Advertisement Restrictions (2023)
• HB 6669 – Public Act No. 23-171 – An Act Protecting Patients and Prohibiting Unnecessary Health Care Costs  (Effective Oct 1, 2023)

Connecticut Child Safety Information

• GSC Sec. 17a-54b – Policies and procedures to secure health, safety and well-being of infants affected at birth by drug or alcohol exposure.
• GSC Sec. 17a-101 – (Formerly Sec. 17-38a). Protection of children from abuse. Mandated reporters. Educational and training programs. Model mandated reporting policy.
• GSC Sec. 17a-101a –  Report of abuse, neglect or injury of child or imminent risk of serious harm to child. Penalty for failure to report. Notification of Chief State’s Attorney.
• GSC Sec. 21a-278a – Penalty for illegal manufacture, distribution, sale, prescription or administration.
• DCF: Enhanced Safety Guidance for Cases Involving Fentanyl and Substance Use (Aug 2023)

Connecticut Compounding Information

• CAC § 20-576-64 – Definitions
• CAC § 20-576-66 – Standards
• CAC § 20-576-69 – Definitions
• CAC § 20-576-71 – Standards
• GSC24 Sec. 20-633b – Sterile compounding pharmacies. Sterile compounding by health care institutions. Requirements. Exemption. Regulations.
• Drug Control Division Inspection Forms (DCP)

Connecticut Coroner/Medical Examiner Information

• GSC Sec. 19a-400. (Formerly Sec. 19-525) – Short title: Medicolegal Investigations Act.
• GSC Sec. 19a-401. (Formerly Sec. 19-526) – Commission on Medicolegal Investigations. Regulations.
• GSC24 Sec. 19a-403. (Formerly Sec. 19-527) – Office of the Chief Medical Examiner. Fees. Regulations.
• GSC24 Sec. 19a-404. (Formerly Sec. 19-528) – Chief Medical Examiner.
• GSC24 Sec. 19a-405. (Formerly Sec. 19-529) – Deputy Chief Medical Examiner. Staff.
• GSC Sec. 19a-406. (Formerly Sec. 19-530) – Powers and duties of Chief Medical Examiner. Certified pathologists. Autopsies.
• GSC24 Sec. 19a-409. (Formerly Sec. 19-533) – Issuance of death certificate.
• CDC Connecticut Coroner/Medical Examiner Laws

Connecticut Drug Checking Information (Test Strips)

• GSC Sec. 21a-240. (Formerly Sec. 19-443) – Definitions
• HB 6768 – Public Act No. 23-52 – An Act Concerning the Department of Consumer Protection’s Recommendations Regarding Prescription drug regulation. (Effective Jan 1, 2024)
• HB 5430 – Public Act No 22-108 – An Act Concerning Opioids. (Effective July 1, 2022)

Connecticut Drug Cleanup Information (Methamphetamine & Fentanyl Labs)

• NO STATE LAWS OR REGULATIONS IDENTIFIED

Connecticut Drug Court Information

• CGS Sec. 51-181b – Drug docket and drug courts.

Connecticut Drug Free Workplace Information

• SB 1201 – Public Act No. 21-1 – An Act Concerning Responsible and Equitable Regulation of Adult Use Cannabis

Connecticut Drugged Driving Information

• GSC Sec. 14-227 – Operation while intoxicated.
• GSC Sec. 14-227a – Operation while under the influence of liquor or drug or while having an elevated blood alcohol content.
• GSC Sec. 14-227b – Implied consent to test operator’s blood, breath or urine and to nontestimonial portion of drug influence evaluation. Testing procedures. License suspension. Hearing.
• GSC Sec. 14-227c – Blood, breath or urine sample and drug influence evaluation required following accident resulting in death or serious physical injury.
• GSC Sec. 14-227d – Pilot program permitting issuance of warning to and twenty-four-hour revocation of license of certain alleged offenders.
• GSC Sec. 14-227e – Community service for persons convicted of operation while under the influence of liquor or drug.
• GSC Sec. 14-227f – . Alcohol and drug addiction treatment program. Waiver. Appeal. Regulations.

Connecticut Drug Violations Information

• GSC24 Sec. 19a-12e – Petition re inability of health care professional to practice with reasonable skill or safety. Report re arrest or disciplinary action. Investigation. Disclosure. Procedure.
• GSC Sec. 21a-105. (Formerly Sec. 19-225) – Adulterated drugs and devices.
• GSC24 Sec. 21a-106. (Formerly Sec. 19-226) – Misbranded drugs and devices.
• GSC Sec. 21a-108. (Formerly Sec. 19-227) – Illegal obtaining or supplying of drugs. Forged labels.
• GSC Sec. 21a-240. (Formerly Sec. 19-443) – Definitions
• GSC Sec 21a – Chapter 420b – Dependency- Producing Drugs
• GSC24 – Sec 21a – Chapter 420b – Dependency-Producing Drugs
• GSC Sec. 53a-139 – Forgery in the second degree: Class D felony
• Connecticut eRegulations System: Opioid Warning Labels Policies and Procedures – November 2023
• SB 6718 – Public Act 23-100 – An Act Concerning the Safe Storage and Disposal of Certain Prescription Drugs, Illegal Drugs and Cannabis and Cannabis Products.
• HB 6768 – Public Act No. 23-52 – An Act Concerning the Department of Consumer Protection’s Recommendations Regarding Prescription drug regulation. (Effective Jan 1, 2024)
• HB 5430 – Public Act No 22-108 – An Act Concerning Opioids. (Effective July 1, 2022)

Connecticut Electronic Prescribing Information

• CGS24 Sec. 21a-249. (Formerly Sec. 19-457) – Prescription requirements.
• HB 7052 – Public Act 17-131 – An Act Preventing Prescription Opioid Diversion and Abuse (Effective June 30, 2017)

Connecticut First Responder Deflection Program(s) Information

• GSC Sec. 17a-486 – (Formerly Sec. 17a-681a) – Clinical assessment of certain persons charged with misdemeanor or felony.
• Civil Citation Diversion & Deflection Network

Connecticut 911 – Good Samaritan Information

• GSC Sec. 17a-714a – Immunity and no violation of standard of care for prescribing, dispensing or administering opioid antagonist. Amendment of local emergency medical services plan.
• GSC24 Sec. 21a-267. (Formerly Sec. 19-472a) – Penalty for use, possession or delivery of drug paraphernalia associated with a controlled substance other than cannabis. Immunity.
• GSC Sec. 21a-279. (Formerly Sec. 19-481) – Penalty for illegal possession of a controlled substance other than cannabis. Alternative sentences. Immunity.
• GSC Sec. 52-557b – “Good samaritan law”. Immunity from liability for emergency medical assistance, first aid or medication by injection. Immunity from liability re automatic external defibrillators. School personnel not required to render emergency first aid or administer medication by injection.
• ORS: Refresher Video for Law Enforcement (2023 Memo)

Connecticut Medical Marijuana, Recreational Marijuana & CBD Information

• GSC Sec. 21a – Chapter 420h – Regulation of Adult Use Cannabis
• GSC24 Sec. 21a – Chapter 420h – Regulation of Adult Use Cannabis
• HB 5596 – Public Act No. 21-9 – An Act Concerning Telehealth. (Effective May 10, 2021)
• SB 1201 – Public Act No. 21-1 – An Act Concerning Responsible and Equitable Regulation of Adult Use Cannabis
• Marijuana Policy Project (MPP) – Colorado
• Medical Marijuana Resources for Municipal Officials

Connecticut Medication Assisted Treatment (MAT) Information

• CAC Sec. 19a-495-570 – Licensure of private freestanding facilities for the care or the treatment of substance abusive or dependent persons
• GSC24 – Sec. 19a-491. (Formerly Sec. 19-577) – License and certificate required. Application. Assessment of civil penalties or a consent order. Fees. Minimum service quality standards. Regulations. Professional liability insurance. Prohibition. Maintenance of medical records.
• GSC Sec. 19a-495c – Methadone delivery and related substance use treatment services to persons in a nursing home facility.

Connecticut Naloxone Information

• GSC Sec. 10a-55t – Policy re availability and use of opioid antagonists on campus required.
• GSC Sec. 10-212a – Administration of medications in schools, at athletic events and to children in school readiness programs.
• GSC24 Sec. 17a-674h – Opioid Antagonist Bulk Purchase Fund. Report.
• GSC Sec. 17a-714a – Immunity and no violation of standard of care for prescribing, dispensing or administering opioid antagonist. Amendment of local emergency medical services plan.
• GSC Sec. 20-14o – Prescriptions for opioid drugs.
• GSC Sec. 20-633c – Prescribing of opioid antagonists by licensed pharmacists. Regulations.
• GSC Sec. 20-633d – Medical protocol standing order for dispensing of opioid antagonists by licensed pharmacists. Regulations.
• GSC24 Sec. 21a-286 – Agreements for distribution and administration of opioid antagonists. Secure boxes, vending machines and secured machines. Test strips. Regulations.
• HB 6856 – Public Act 15-198 – An Act Concerning Substance Abuse and Opioid Overdose Prevention (Effective Oct 1, 2015)
• HB 6768 – Public Act No. 23-52 – An Act Concerning the Department of Consumer Protection’s Recommendations Regarding Prescription drug regulation. (Effective Jan 1, 2024)
• HB 9 – Public Act No 23-97 – An Act Concerning Health and Wellness for Connecticut Residents. (Effective June 28, 2023)

Connecticut Needle Exchange Programs (NEP) & Syringe Services programs (SSP) Information

• GSC Sec. 19a-124 – Syringe services programs.
• GSC Sec. 19a-124a – Donation of vans to entities operating needle exchange programs.
• GSC Sec. 21a-240. (Formerly Sec. 19-443) – Definitions
• GSC24 Sec. 21a-267. (Formerly Sec. 19-472a) – Penalty for use, possession or delivery of drug paraphernalia associated with a controlled substance other than cannabis. Immunity.
• GSC24 – Chapter 417 – General Provisions. Pure Food and Drugs. [Sec. 21a-65 – Sec 21a-70k]
• SB 202 – Public Act No. 24-80 – An Act Concerning the Department of Consumer Protection’s Recommendations Regarding Prescription Drug Control. (Effective May 30, 2024)
• SB 895 – Public Act No. 21-192 – An Act Concerning Changes to Various Pharmacy Statutes. (Effective July 13, 2021)

Connecticut Neonatal Abstinence Syndrome (NAS), Neonatal Opioid Withdrawal (NOWS) Information

• GSC Sec. 17a-710. (Formerly Sec. 19a-4f) – Treatment programs for pregnant women with substance use disorders and their children.

Connecticut Opioid Litigation Proceeds Information

• GSC Sec. 17a-674b – Opioid Settlement Fund. Definitions.
• GSC24 Sec. 17a-674c – Opioid Settlement Fund. Establishment. Report. Spending of funds.
• GSC24 Sec. 17a-674d – Opioid Settlement Advisory Committee. Membership. Duties.
• GSC Sec. 17a-674e – Disbursement of moneys from Opioid Settlement Fund.
• GSC Sec. 17a-674f –  Opioid Settlement Committee. Report.
• GSC Sec. 17a-674g – Opioid Settlement Fund. Funding of trust for direct support and services for survivors and victims of opioid epidemic and certain family members of such survivors and victims.
• HB 5044 – Public Act 22-48 – An Act Implementing the Governor’s Budget Recommendations Regarding the Use of Opioid Litigation Proceeds (Effective July 1, 2022)

Connecticut Overdose Prevention Centers (OPC), Supervised Consumption Sites (SCS), Supervised Injection Facilities (SIF) Information

• GSC 24 – Sec. 17a-673c –  Pilot program to prevent drug overdoses. Establishment of harm reduction centers in three municipalities. Funding.

Connecticut Overdose Surveillance/Reporting Information

• GSC Sec. 17a-667 – Connecticut Alcohol and Drug Policy Council.
• GSC Sec. 17a-667a – Fact sheet re opioids and opioid use disorder. Marketing campaign and public service announcements. Information portal re detoxification and rehabilitation beds and slots for outpatient treatment. Report. Working groups re disposal of opioid drugs and substance abuse treatment referral programs.
• GSC Sec. 17a-670. (Formerly Sec. 19a-2d) – Regional planning for substance abuse prevention and treatment.
• GSC Sec. 17a-671. (Formerly Sec. 19a-2e) – Subregional planning and action councils.
• GSC Sec. 17a-672. (Formerly Sec. 19a-2f) – Scope of powers and duties.
• GSC Sec. 17a-673. (Formerly Sec. 19a-4e) – Treatment programs. Annual report of facilities.
• GSC Sec. 17a-673a – Opioid use disorder treatment program requirements.
• GSC Sec. 54-142s – State-wide information technology system for sharing of criminal justice information.
• SB 483 – Public Act 18-166 – An Act Concerning the Prevention and Treatment of Opioid Dependency and Opioid Overdose in the State. (Effective June 14, 2018)

Connecticut Pain Management Information

• GSC
• CT Laws Impacting Prescribing and Practice (DCP 2023)
• HB 7159 – Public Act No 19-191 – An Act Addressing Opioid Use (Effective Oct 1, 2019)

Connecticut Pill Press & Counterfeit Medication Information

• GSC Sec. 21a-93. (Formerly Sec. 19-213) – Prohibited acts.
• GSC Sec. 21a-95. (Formerly Sec. 19-215) – Penalties.

Connecticut Prescription Drug Drop-Off Information

• GSC Sec. 20-576a – Acceptance and disposal of unused prescription drugs at pharmacies. Regulations.
• SB 6718 – Public Act 23-100 – An Act Concerning the Safe Storage and Disposal of Certain Prescription Drugs, Illegal Drugs and Cannabis and Cannabis Products.
• SB 1 – Public Act No. 24-19 – An Act Concerning the Health and Safety of Connecticut Residents (Effective Oct 1, 2024)

Connecticut Prescription Drug Importation Information

• SB 8 – An Act Concerning drug Affordability (Pending 2024)

Connecticut Prescription Drug Monitoring Program Information

• GSC Sec. 21a-240. (Formerly Sec. 19-443) – Definitions.
• GSC Sec. 21a-254. (Formerly Sec. 19-461) – Designation of restricted drugs or substances by regulations. Records required by chapter. Electronic prescription drug monitoring program. Information reporting of diabetes drugs and devices.
• GSC Sec. 21a-254a – Appointment of prescription drug monitoring working group. Membership.
• GSC Sec. 21a-317. (Formerly Sec. 19-504l) – Registration required. Notification of transportation of a controlled substance to treat a patient at an alternate location required. Report of dispensation of a controlled substance at an alternate location required.
• SB 895 – Public Act No. 21-192 – An Act Concerning Changes to Various Pharmacy Statutes. (Effective July 13, 2021)

Connecticut Precursor Chemicals/Including Pseudoephedrine Information

• GSA Sec. 21a-277. (Formerly Sec. 19-480) – Penalty for illegal manufacture, distribution, sale, prescription, dispensing.
• GSA Sec. 21a-278. (Formerly Sec. 19-480a) – Penalty for illegal manufacture, distribution, sale, prescription or administration by non-drug-dependent person.
• GSA Sec. 21a-278a – Penalty for illegal manufacture, distribution, sale, prescription or administration.

Connecticut Prison/Jail Program(s) Information

• GSC Sec. 17a-691. (Formerly Sec. 19a-127) – Definitions.
• GSC Sec. 17a-692. (Formerly Sec. 19a-127a) – Responsibilities and authority of Court Support Services Division re persons ordered treated for alcohol or drug dependency.
• GSC Sec. 17a-693. (Formerly Sec. 19a-127b) – Order for examination for alcohol or drug dependency.
• GSC Sec. 17a-694. (Formerly Sec. 19a-127c) – Examination for alcohol or drug dependency. Report.
• GSC Sec. 17a-695. (Formerly Sec. 19a-127d) – Motion for suspension of prosecution and treatment for alcohol and drug dependency.
• GSC Sec. 17a-696. (Formerly Sec. 19a-127e) – Order for suspension of prosecution and treatment for alcohol or drug dependency.
• GSC Sec. 17a-697. (Formerly Sec. 19a-127f) – Completion of treatment program. Dismissal of charges.
• GSC Sec. 17a-698. (Formerly Sec. 19a-127g) – Modification or termination of suspension of prosecution prior to completion of treatment program.
• GSC Sec. 17a-699. (Formerly Sec. 19a-127h) – Order of treatment for alcohol or drug dependency of convicted person.
• GSC Sec. 17a-700. (Formerly Sec. 19a-127i) – Completion of treatment program by convicted person.
• GSC Sec. 17a-701. (Formerly Sec. 19a-127j) – Modification of sentence or terms of probation prior to completion of treatment program by convicted person.

Connecticut School Programs/Information

•  GSC Sec. 10a-55t – Policy re availability and use of opioid antagonists on campus required.
• GSC Sec. 10-212a – Administration of medications in schools, at athletic events and to children in school readiness programs.
• HB 7159 – Public Act No 19-191 – An Act Addressing Opioid Use (Effective Oct 1, 2019)
• SB 1 – Public Act No. 22-80 – An Act Concerning Childhood Mental and Physical Health Services in Schools. (Effective July 1, 2022)
• 20-614

Connecticut Sober Living Homes/Recovery Residence Information

• GSC Sec. 17a-716 – Sober living homes. Report of certified status. List of homes. Distribution of disclosure form. Regulations.

Connecticut Substance Abuse Services Information

• GSC Sec. 17a-667 – Connecticut Alcohol and Drug Policy Council.
• GSC Sec. 17a-667a – Fact sheet re opioids and opioid use disorder. Marketing campaign and public service announcements. Information portal re detoxification and rehabilitation beds and slots for outpatient treatment. Report. Working groups re disposal of opioid drugs and substance abuse treatment referral programs.
• GSC Sec. 17a-670. (Formerly Sec. 19a-2d) – Regional planning for substance abuse prevention and treatment.
• GSC Sec. 17a-671. (Formerly Sec. 19a-2e) – Subregional planning and action councils.
• GSC Sec. 17a-672. (Formerly Sec. 19a-2f) – Scope of powers and duties.
• GSC Sec. 17a-673. (Formerly Sec. 19a-4e) – Treatment programs. Annual report of facilities.
• GSC Sec. 17a-673a – Opioid use disorder treatment program requirements.
• GSC Sec. 17a-685. (Formerly Sec. 19a-126e) – Application for involuntary commitment. Notice of hearing. Order of commitment. Recommitment. Discharge. Application for termination of commitment or recommitment and discharge.

Connecticut Telemedicine/Telehealth Information

• GSC Sec. 19a-906 – Telehealth services.
• HB 5596 – Public Act No. 21-9 – An Act Concerning Telehealth. (Effective May 10, 2021)
• HB 5198 – Public Act No. 24-110 – An Act Concerning Telehealth.

Last Updated – 6/29/2024

Please report any broken links to tech@naddi.org